Available in English and Spanish, this e-newsletter separates fact from fiction on over 40 heart topics by Texas Heart Medical Group's Dr. Stephanie Coulter.
Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Innovative Technologies & Techniques is produced at THI and explores promising advances in medicine that aim to extend the life of cardiac patients and patients at risk for series heart and vascular conditions. In response to the evolving pandemic, emerging topics related to COVID-19 are featured in the special Cardiology in the Time of COVID-19 episodes.
Our progress would not be possible without our donor community. Help support our mission by giving today.
The Cardiovascular Pathology Research department at Texas Heart Institute (THI) works to conduct original research and to support THI research investigators with core lab services. Additionally, the department provides specialized pathology and histology services including Transmission Electron Microscopy (TEM) and Low and High Vacuum Scanning Electron Microscopy (SEM) with Elemental Analysis on a fee-for-service basis to medical companies, institutions and investigators outside of THI.
As a vital part of the Institute’s overall cardiovascular research team, THI’s cardiovascular pathologists work to provide researchers with critical information they need to progress their studies forward.
Pamela Potts, Administrative Director
Email: ppotts@texasheart.org
Phone: (832) 355-6524
Our GLP Compliant Laboratory for preclinical studies has a CLIA Certificate of Compliance for Transmission Electron Microscopy (TEM) clinical services. The lab supports Histology and Electron Microscopy studies involving stents, valves, aneurysm coils, pacing leads, endovascular devices and lasers.
